Galapagos Extends Service Collaboration With Chiesi Farmaceutici

Galapagos NV (GLPG)’s BioFocus service division extended its collaboration with Chiesi Farmaceutici, a privately owned Italian pharmaceutical company, for a second time. This extension is valued at 2.8 million euros, Galapagos said in a statement.

To contact the editor responsible for this story: Andrew Clapham at

Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.